The impact of multicancer early detection tests on cancer stage shift: A 10‐year microsimulation model
MCED testing has the potential to substantially reduce late-stage cancer diagnoses, improve outcomes across multiple cancer types, and address a critical gap in screening.
Authors
- Ashish A. Deshmukh (ORCID: https://orcid.org/0000-0001-8936-8108)
- Jade Xiao (ORCID: https://orcid.org/0000-0002-3517-9456)
- Andrew Briggs (ORCID: https://orcid.org/0000-0002-0777-1997)
- Andrew K. ElHabr (ORCID: https://orcid.org/0000-0003-3778-5350)
- Sana Raoof (ORCID: https://orcid.org/0000-0003-2977-8687)
- Paul J. Limburg (ORCID: https://orcid.org/0000-0002-2428-5675)
- Jagpreet Chhatwal (ORCID: https://orcid.org/0000-0001-8741-4430)
- Tomasz M. Beer (ORCID: https://orcid.org/0000-0001-5600-9993)
- Ahmet Burak Ozbay (ORCID: https://orcid.org/0000-0002-8624-6313)
- Christopher Tyson (ORCID: https://orcid.org/0009-0003-0418-3502)
- A. Mark Fendrick (ORCID: https://orcid.org/0000-0002-7734-6742)
- Xiting Cao
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Harvard University (US)
- Medical University of South Carolina (US)
- University of Michigan (US)
- Massachusetts General Hospital (US)
- Systems Analytics (United States) (US)
- London School of Hygiene & Tropical Medicine (GB)
- Exact Sciences (United States) (US)
- Decision Systems (United States) (US)
Publication Details
- Journal
- Cancer
- Published
- 2025-11-10
- DOI
- https://doi.org/10.1002/cncr.70075
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 0.00